- Joined
- Feb 11, 2007
- Messages
- 10
- Reaction score
- 0
Interesting news:
Quest buying AmeriPath:http://www.topix.net/com/dgx/2007/04/quest-buying-ameripath
This acquisition will establish our leading position in cancer diagnostics with a focus on dermatopathology, anatomic pathology and molecular diagnostics
DGX - Cramer's Take - Stockpickr ) agreed to pay $1.23 billion for AmeriPath, a closely held diagnostics company owned by Welsh Carson Anderson & Stowe. (http://www.topix.net/com/dgx/2007/04/quest-buying-ameripath)
Any thoughts on this aquisition ? Will it affect dermpath fellowships ran by AmeriPath affiliates? Any affect on the practice of Anatomical Pathology in the future?
Quest buying AmeriPath:http://www.topix.net/com/dgx/2007/04/quest-buying-ameripath
This acquisition will establish our leading position in cancer diagnostics with a focus on dermatopathology, anatomic pathology and molecular diagnostics
DGX - Cramer's Take - Stockpickr ) agreed to pay $1.23 billion for AmeriPath, a closely held diagnostics company owned by Welsh Carson Anderson & Stowe. (http://www.topix.net/com/dgx/2007/04/quest-buying-ameripath)
Any thoughts on this aquisition ? Will it affect dermpath fellowships ran by AmeriPath affiliates? Any affect on the practice of Anatomical Pathology in the future?